Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Empire Dental Arts is a U.S. dental partnership organization that provides operational and centralized back-office support to affiliated dental practices, including functions such as human resources, payroll, accounting, vendor management, insurance, accounts receivable, IT, and clinic-level operations. The company was established in 2017 in Mentor, Ohio and expanded through acquisitions of regional dental practices. It operates in healthcare services rather than drug development, so it does not have a biopharma pipeline, therapeutic targets, or clinical-stage assets. Empire Dental Arts was acquired by Evolution Capital Partners in 2020, and by July 2025 the business was being presented publicly as Lotus Dental Arts/Lotus Dental Health Partners under new ownership while retaining the same management, doctors, and teams. For a biotech analyst, this is best categorized as a commercial dental services organization rather than a biotech, pharma, or medtech innovator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Empire Dental Arts.